Natural Product: NPC599805

Natural Product IDNPC599805
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
 VGGGPCQERPFHOB-RDBSUJKOSA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL29292
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey VGGGPCQERPFHOB-RDBSUJKOSA-N
Standard InCHI InChI=1S/C16H24N2O4/c1-10(2)8-13(16(21)22)18-15(20)14(19)12(17)9-11-6-4-3-5-7-11/h3-7,10,12-14,19H,8-9,17H2,1-2H3,(H,18,20)(H,21,22)/t12-,13+,14+/m1/s1
SMILES CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(=O)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   308.17 Volume:   320.708
?
Van der Waals volume.
Dense:   0.961 LogP:   -0.184
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   1.058
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
 LogS:   -1.359
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   9.0 Rigid Bonds:   8.0
TPSA:   112.65
?
Topological Polar Surface Area.
 H-Bond Acceptor:   6.0
H-Bond Donor:   5.0 Rings:   1.0
Heavy Atoms:   6.0

MedChem Properties

QED Drug-Likeness Score:   0.559 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   2.938 Fsp3:   0.5
MCE-18:   20.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
 Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Rejected
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.529 Fluc inhibitor:   0.004
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.03
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
 Green fluorescence:   0.359
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.007 Promiscuous compounds:   0.024

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.828 MDCK Permeability:   -4.763
Pgp-inhibitor:   0.0 Pgp-substrate:   0.719
PAMPA:   0.943
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
 Human Intestinal Absorption (HIA):   0.003
20% Bioavailability (F20%):   0.141 30% Bioavailability (F30%):   0.58
50% Bioavailability (F50%):   0.72

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.003 MRP1:   0.172
Plasma Protein Binding (PPB):   65.768% Volume Distribution (VD):   -0.357
Fu: 35.001%
?
The fraction unbound in plasms.
 OATP1B1 inhibitor:   0.054
OATP1B3 inhibitor:   0.774 BCRP inhibitor:   0.0
BSEP inhibitor:   0.099

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.001 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.66 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   0.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.0
HLM stability:   0.0
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  3.759 Half-life (T1/2):  1.815

ADMET: Toxicity

hERG Blockers:  0.143 hERG Blockers (10um):  0.053
Human Hepatotoxicity (H-HT):  0.91 Drug-induced Liver Injury (DILI):  0.582
AMES Toxicity:  0.083 Rat Oral Acute Toxicity:  0.565
Maximum Recommended Daily Dose:  0.767 Skin Sensitization:  0.993
Carcinogencity:  0.004 Eye Corrosion:  0.001
Eye Irritation:  0.229 Respiratory Toxicity:  0.723
Drug-induced Neurotoxicity:  0.775 Ototoxicity:  0.776
Hematotoxicity:  0.061 Drug-induced Nephrotoxicity:  0.955
Genotoxicity:  0.895 RPMI-8226 Immunitoxicity:  0.069
A549 Cytotoxicity:  0.019 Hek293 Cytotoxicity:  0.016
BCF:   0.248
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
 IGC50:   3.0
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.308
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
 LC50FM:   3.483
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO53436 Streptomyces HCCB10043 Genus Streptomycetaceae Bacteria n.a. n.a. n.a. Database[COCONUT]
NPO18459 Streptomyces olivoreticuli Species Streptomycetaceae Bacteria n.a. n.a. n.a. Database[COCONUT]
NPO60815 Streptomyces olivoreticuli ATCC 31159 Genus Streptomycetaceae Bacteria n.a. n.a. n.a. Database[COCONUT]
NPO59671 Streptomyces olivoreticuli MD976-C7 Genus Streptomycetaceae Bacteria n.a. n.a. n.a. Database[COCONUT]
NPO63310 Streptomyces sp. HCCB10043 Species Streptomycetaceae Bacteria n.a. n.a. n.a. Database[COCONUT]
NPO18459 Streptomyces olivoreticuli Species Streptomycetaceae Bacteria n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT239 Individual protein Cholecystokinin A receptor Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT223 Individual protein Alpha-2b adrenergic receptor Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT152 Individual protein Nuclear factor erythroid 2-related factor 2 Homo sapiens Potency n.a. 8199.5 nM PubChem BioAssay data set
NPT1553 Individual protein Aminopeptidase N Sus scrofa Ki = 7800.0 nM PMID[3184126]
NPT2553 Individual protein Aminopeptidase N Homo sapiens IC50 = 54700.0 nM PMID[30737134]
NPT1410 Individual protein GABA receptor alpha-1 subunit Rattus norvegicus AC50 > 30000.0 nM PMID[37468498]
NPT1553 Individual protein Aminopeptidase N Sus scrofa IC50 = 1640.0 nM PMID[24755524]
NPT1592 Individual protein Dipeptidyl peptidase IV Homo sapiens IC50 > 100.0 ug.mL-1 PMID[9464355]
NPT234 Individual protein C-C chemokine receptor type 2 Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT2520 Individual protein Leukotriene A4 hydrolase Homo sapiens IC50 = 4000.0 nM PMID[18674901]
NPT245 Individual protein Dopamine D4 receptor Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT204 Individual protein Acetylcholinesterase Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT227 Individual protein Beta-3 adrenergic receptor Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT243 Individual protein Dopamine D2 receptor Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT242 Individual protein Dopamine D1 receptor Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT233 Individual protein Carbonic anhydrase II Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT235 Individual protein C-C chemokine receptor type 4 Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT280 Individual protein Matrix metalloproteinase 9 Homo sapiens IC50 n.a. n.a. nM PMID[15582436]
NPT2553 Individual protein Aminopeptidase N Homo sapiens IC50 = 34350.0 nM PMID[29202398]
NPT104 Individual protein Cerebroside-sulfatase Homo sapiens Potency n.a. 849.2 nM PubChem BioAssay data set
NPT2553 Individual protein Aminopeptidase N Homo sapiens Inhibition n.a. n.a. % PMID[22901392]
NPT1553 Individual protein Aminopeptidase N Sus scrofa IC50 = 3800.0 nM PMID[19454370]
NPT213 Individual protein Cytochrome P450 2C19 Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT246 Individual protein Dopamine transporter Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT247 Individual protein Endothelin receptor ET-A Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT227 Individual protein Beta-3 adrenergic receptor Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT219 Individual protein Alpha-1a adrenergic receptor Rattus norvegicus Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT265 Individual protein Muscarinic acetylcholine receptor M4 Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT246 Individual protein Dopamine transporter Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT1553 Individual protein Aminopeptidase N Sus scrofa IC50 = 2100.0 nM PMID[20347318]
NPT1553 Individual protein Aminopeptidase N Sus scrofa IC50 = 5120.0 nM PMID[27322756]
NPT1553 Individual protein Aminopeptidase N Sus scrofa IC50 = 5870.0 nM PMID[21194957]
NPT1553 Individual protein Aminopeptidase N Sus scrofa IC50 = 4180.0 nM PMID[20637634]
NPT228 Individual protein Norepinephrine transporter Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT1553 Individual protein Aminopeptidase N Sus scrofa Ki = 2100.0 nM PMID[28728898]
NPT220 Individual protein Alpha-1b adrenergic receptor Rattus norvegicus Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT2553 Individual protein Aminopeptidase N Homo sapiens IC50 = 2500.0 nM PMID[23860593]
NPT1553 Individual protein Aminopeptidase N Sus scrofa IC50 = 8900.0 nM PMID[22901392]
NPT1788 Individual protein Alpha-1a adrenergic receptor Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT242 Individual protein Dopamine D1 receptor Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT299 Individual protein Androgen Receptor Rattus norvegicus Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT303 Individual protein Vasopressin V1a receptor Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT280 Individual protein Matrix metalloproteinase 9 Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT182 Individual protein Protein kinase C alpha Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT286 Individual protein Receptor protein-tyrosine kinase erbB-2 Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT208 Individual protein Cytochrome P450 1A2 Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT225 Individual protein Beta-1 adrenergic receptor Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT221 Individual protein Alpha-1d adrenergic receptor Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT251 Individual protein Histamine H1 receptor Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT271 Individual protein Delta opioid receptor Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT247 Individual protein Endothelin receptor ET-A Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT275 Individual protein Progesterone receptor Bos taurus IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT278 Individual protein Cathepsin G Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT285 Individual protein Epidermal growth factor receptor erbB1 Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT293 Individual protein Serotonin 4 (5-HT4) receptor Cavia porcellus IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT249 Individual protein Glucocorticoid receptor Homo sapiens AC50 = 20000.0 nM PMID[37468498]
NPT294 Individual protein Serotonin 6 (5-HT6) receptor Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT296 Individual protein Sigma opioid receptor Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT2520 Individual protein Leukotriene A4 hydrolase Homo sapiens IC50 = 266.0 nM PMID[32551007]
NPT290 Individual protein Serotonin 2a (5-HT2a) receptor Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT213 Individual protein Cytochrome P450 2C19 Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT212 Individual protein Cytochrome P450 2C9 Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT267 Individual protein Neuropeptide Y receptor type 1 Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT2553 Individual protein Aminopeptidase N Homo sapiens IC50 = 40000.0 nM PMID[22607877]
NPT1553 Individual protein Aminopeptidase N Sus scrofa IC50 = 3400.0 nM PMID[26629857]
NPT1553 Individual protein Aminopeptidase N Sus scrofa IC50 = 3600.0 nM PMID[19782572]
NPT291 Individual protein Serotonin 2b (5-HT2b) receptor Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT225 Individual protein Beta-1 adrenergic receptor Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT228 Individual protein Norepinephrine transporter Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT263 Individual protein Muscarinic acetylcholine receptor M2 Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT292 Individual protein Serotonin 2c (5-HT2c) receptor Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT301 Individual protein Vascular endothelial growth factor receptor 1 Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT293 Individual protein Serotonin 4 (5-HT4) receptor Cavia porcellus Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT221 Individual protein Alpha-1d adrenergic receptor Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT229 Individual protein Angiotensin II type 2 (AT-2) receptor Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT244 Individual protein Dopamine D3 receptor Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT245 Individual protein Dopamine D4 receptor Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT232 Individual protein Cannabinoid CB1 receptor Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT266 Individual protein Muscarinic acetylcholine receptor M5 Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT274 Individual protein Platelet activating factor receptor Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT264 Individual protein Muscarinic acetylcholine receptor M3 Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT266 Individual protein Muscarinic acetylcholine receptor M5 Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT269 Individual protein Nitric-oxide synthase, brain Rattus norvegicus IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT269 Individual protein Nitric-oxide synthase, brain Rattus norvegicus Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT273 Individual protein Phosphodiesterase 5A Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT275 Individual protein Progesterone receptor Bos taurus Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT289 Individual protein Serotonin 1b (5-HT1b) receptor Rattus norvegicus Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT1553 Individual protein Aminopeptidase N Sus scrofa IC50 = 9400.0 nM PMID[30737134]
NPT1553 Individual protein Aminopeptidase N Sus scrofa IC50 = 1300.0 nM PMID[23510562]
NPT298 Individual protein Neurokinin 2 receptor Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT216 Individual protein Adenosine A1 receptor Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT222 Individual protein Alpha-2a adrenergic receptor Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT282 Individual protein MAP kinase ERK2 Homo sapiens Delta TM = 0.15 C Tm Shift (DSF) assay results for EUbOPEN Chemogenomics Library
NPT216 Individual protein Adenosine A1 receptor Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT288 Individual protein Serotonin 1a (5-HT1a) receptor Rattus norvegicus IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT237 Individual protein Interleukin-8 receptor A Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT240 Individual protein Cytochrome P450 2A6 Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT2769 Individual protein Thromboxane A2 receptor Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT1553 Individual protein Aminopeptidase N Sus scrofa Ki = 3500.0 nM PMID[24055078]
NPT226 Individual protein Beta-2 adrenergic receptor Homo sapiens Potency n.a. 12995.3 nM PubChem BioAssay data set
NPT271 Individual protein Delta opioid receptor Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT2520 Individual protein Leukotriene A4 hydrolase Homo sapiens IC50 = 10100.0 nM PMID[28065501]
NPT294 Individual protein Serotonin 6 (5-HT6) receptor Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT260 Individual protein Melanocortin receptor 5 Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT1553 Individual protein Aminopeptidase N Sus scrofa IC50 = 8100.0 nM PMID[22607877]
NPT2553 Individual protein Aminopeptidase N Homo sapiens Inhibition = 85.0 % PMID[12930151]
NPT1553 Individual protein Aminopeptidase N Sus scrofa IC50 = 3800.0 nM PMID[19969464]
NPT2520 Individual protein Leukotriene A4 hydrolase Homo sapiens Delta Tm = 5.1 degrees C PMID[27651294]
NPT252 Individual protein Histamine H2 receptor Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT1553 Individual protein Aminopeptidase N Sus scrofa IC50 = 2100.0 nM PMID[18524593]
NPT1432 Individual protein Serine/threonine-protein kinase Aurora-A Homo sapiens Delta TM = -0.07 C Tm Shift (DSF) assay results for EUbOPEN Chemogenomics Library
NPT2553 Individual protein Aminopeptidase N Homo sapiens Ki = 2370.0 nM PMID[31251594]
NPT2520 Individual protein Leukotriene A4 hydrolase Homo sapiens IC50 = 4000.0 nM DOI[10.1016/S0960-894X(01)80464-9]
NPT1163 Individual protein Glutamate (NMDA) receptor subunit zeta 1 Rattus norvegicus AC50 > 30000.0 nM PMID[37468498]
NPT2520 Individual protein Leukotriene A4 hydrolase Homo sapiens IC50 = 300.0 nM PMID[27651294]
NPT108 Individual protein Estrogen receptor alpha Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT281 Individual protein MAP kinase ERK1 Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT287 Individual protein Leukocyte common antigen Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT2729 Individual protein Tyrosine-protein kinase ABL Homo sapiens Delta TM = -0.05 C Tm Shift (DSF) assay results for EUbOPEN Chemogenomics Library
NPT2553 Individual protein Aminopeptidase N Homo sapiens IC50 = 54700.0 nM PMID[29859750]
NPT2520 Individual protein Leukotriene A4 hydrolase Homo sapiens Kd = 2050.0 nM PMID[27651294]
NPT280 Individual protein Matrix metalloproteinase 9 Homo sapiens Inhibition n.a. n.a. % PMID[26386821]
NPT216 Individual protein Adenosine A1 receptor Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT264 Individual protein Muscarinic acetylcholine receptor M3 Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT252 Individual protein Histamine H2 receptor Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT253 Individual protein HMG-CoA reductase Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT261 Individual protein Monoamine oxidase A Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT283 Individual protein MAP kinase p38 alpha Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT248 Individual protein Estrogen receptor beta Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT243 Individual protein Dopamine D2 receptor Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT265 Individual protein Muscarinic acetylcholine receptor M4 Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT251 Individual protein Histamine H1 receptor Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT279 Individual protein Leukocyte elastase Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT182 Individual protein Protein kinase C alpha Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT284 Individual protein Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT270 Individual protein Nitric oxide synthase, inducible Mus musculus Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT274 Individual protein Platelet activating factor receptor Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT255 Individual protein Leukotriene C4 synthase Cavia porcellus IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT259 Individual protein Melanocortin receptor 4 Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT262 Individual protein Muscarinic acetylcholine receptor M1 Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT270 Individual protein Nitric oxide synthase, inducible Mus musculus IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT248 Individual protein Estrogen receptor beta Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT1553 Individual protein Aminopeptidase N Sus scrofa IC50 = 3400.0 nM PMID[23453219]
NPT2553 Individual protein Aminopeptidase N Homo sapiens IC50 = 19400.0 nM DOI[10.1016/S0960-894X(01)80519-9]
NPT262 Individual protein Muscarinic acetylcholine receptor M1 Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT296 Individual protein Sigma opioid receptor Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT1553 Individual protein Aminopeptidase N Sus scrofa IC50 = 5580.0 nM PMID[23860593]
NPT290 Individual protein Serotonin 2a (5-HT2a) receptor Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT283 Individual protein MAP kinase p38 alpha Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT1553 Individual protein Aminopeptidase N Sus scrofa IC50 = 2400.0 nM PMID[17433673]
NPT224 Individual protein Alpha-2c adrenergic receptor Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT1240 Individual protein Solute carrier family 15 member 1 Rattus norvegicus Activity n.a. n.a. n.a. PMID[8531138]
NPT249 Individual protein Glucocorticoid receptor Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT2520 Individual protein Leukotriene A4 hydrolase Homo sapiens Ki = 320.0 nM PMID[27651294]
NPT2520 Individual protein Leukotriene A4 hydrolase Homo sapiens Kd = 4630.0 nM PMID[27651294]
NPT300 Individual protein Thromboxane-A synthase Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT109 Individual protein Cytochrome P450 3A4 Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT229 Individual protein Angiotensin II type 2 (AT-2) receptor Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT223 Individual protein Alpha-2b adrenergic receptor Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT240 Individual protein Cytochrome P450 2A6 Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT30 Individual protein Cyclooxygenase-1 Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT31 Individual protein Cyclooxygenase-2 Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT242 Individual protein Dopamine D1 receptor Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT280 Individual protein Matrix metalloproteinase 9 Homo sapiens IC50 n.a. n.a. n.a. PMID[26386821]
NPT1592 Individual protein Dipeptidyl peptidase IV Homo sapiens IC50 > 100.0 ug.mL-1 PMID[10098663]
NPT1592 Individual protein Dipeptidyl peptidase IV Homo sapiens IC50 > 324300.0 nM PMID[10098663]
NPT1553 Individual protein Aminopeptidase N Sus scrofa IC50 = 3640.0 nM PMID[34917257]
NPT252 Individual protein Histamine H2 receptor Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT271 Individual protein Delta opioid receptor Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT295 Individual protein Serotonin transporter Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT257 Individual protein Arachidonate 15-lipoxygenase Oryctolagus cuniculus Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT226 Individual protein Beta-2 adrenergic receptor Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT291 Individual protein Serotonin 2b (5-HT2b) receptor Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT2553 Individual protein Aminopeptidase N Homo sapiens Inhibition = 77.6 % PMID[28803047]
NPT2553 Individual protein Aminopeptidase N Homo sapiens IC50 = 800.0 nM PMID[28803047]
NPT260 Individual protein Melanocortin receptor 5 Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT261 Individual protein Monoamine oxidase A Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT279 Individual protein Leukocyte elastase Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT282 Individual protein MAP kinase ERK2 Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT255 Individual protein Leukotriene C4 synthase Cavia porcellus Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT145 Individual protein Mu opioid receptor Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT257 Individual protein Arachidonate 15-lipoxygenase Oryctolagus cuniculus IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT1553 Individual protein Aminopeptidase N Sus scrofa IC50 = 3100.0 nM PMID[19299146]
NPT287 Individual protein Leukocyte common antigen Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT204 Individual protein Acetylcholinesterase Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT218 Individual protein Adenosine A3 receptor Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT217 Individual protein Adenosine A2a receptor Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT218 Individual protein Adenosine A3 receptor Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT1553 Individual protein Aminopeptidase N Sus scrofa IC50 = 5550.0 nM PMID[21911297]
NPT219 Individual protein Alpha-1a adrenergic receptor Rattus norvegicus IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT145 Individual protein Mu opioid receptor Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT1553 Individual protein Aminopeptidase N Sus scrofa Ki = 0.5 nM PMID[22796349]
NPT212 Individual protein Cytochrome P450 2C9 Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT1553 Individual protein Aminopeptidase N Sus scrofa IC50 = 3000.0 nM PMID[19423354]
NPT295 Individual protein Serotonin transporter Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT2553 Individual protein Aminopeptidase N Homo sapiens IC50 = 40000.0 nM PMID[23528299]
NPT1240 Individual protein Solute carrier family 15 member 1 Rattus norvegicus Ki = 1500000.0 nM PMID[11007306]
NPT1241 Individual protein Oligopeptide transporter, kidney isoform Rattus norvegicus Ki = 18000.0 nM PMID[11007306]
NPT1240 Individual protein Solute carrier family 15 member 1 Rattus norvegicus Activity n.a. n.a. n.a. PMID[9190878]
NPT2553 Individual protein Aminopeptidase N Homo sapiens IC50 = 29670.0 nM PMID[23510562]
NPT1553 Individual protein Aminopeptidase N Sus scrofa Ki = 3730.0 nM PMID[22901392]
NPT1237 Individual protein Oligopeptide transporter small intestine isoform Homo sapiens Activity n.a. n.a. n.a. PMID[20190787]
NPT1037 Individual protein Solute carrier family 15 member 2 Homo sapiens Activity n.a. n.a. n.a. PMID[20190787]
NPT1553 Individual protein Aminopeptidase N Sus scrofa IC50 = 5.0 nM PMID[3897541]
NPT208 Individual protein Cytochrome P450 1A2 Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT276 Individual protein Angiotensin-converting enzyme Oryctolagus cuniculus IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT244 Individual protein Dopamine D3 receptor Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT1553 Individual protein Aminopeptidase N Sus scrofa IC50 = 8100.0 nM PMID[23528299]
NPT297 Individual protein Neurokinin 1 receptor Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT298 Individual protein Neurokinin 2 receptor Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT1553 Individual protein Aminopeptidase N Sus scrofa IC50 = 2400.0 nM PMID[19683842]
NPT253 Individual protein HMG-CoA reductase Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT278 Individual protein Cathepsin G Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT13 Individual protein Tyrosine-protein kinase LCK Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT273 Individual protein Phosphodiesterase 5A Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT285 Individual protein Epidermal growth factor receptor erbB1 Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT1584 Individual protein Cytosol aminopeptidase Sus scrofa IC50 = 5200.0 nM PMID[27624521]
NPT1553 Individual protein Aminopeptidase N Sus scrofa IC50 = 13100.0 nM PMID[19329328]
NPT2553 Individual protein Aminopeptidase N Homo sapiens IC50 = 16000.0 nM PMID[24900417]
NPT234 Individual protein C-C chemokine receptor type 2 Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT239 Individual protein Cholecystokinin A receptor Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT222 Individual protein Alpha-2a adrenergic receptor Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT2553 Individual protein Aminopeptidase N Homo sapiens IC50 = 20120.0 nM PMID[23453219]
NPT263 Individual protein Muscarinic acetylcholine receptor M2 Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT225 Individual protein Beta-1 adrenergic receptor Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT2553 Individual protein Aminopeptidase N Homo sapiens IC50 = 40650.0 nM PMID[27670098]
NPT217 Individual protein Adenosine A2a receptor Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT246 Individual protein Dopamine transporter Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT263 Individual protein Muscarinic acetylcholine receptor M2 Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT299 Individual protein Androgen Receptor Rattus norvegicus IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT2553 Individual protein Aminopeptidase N Homo sapiens IC50 = 17340.0 nM PMID[27670098]
NPT256 Individual protein Cysteinyl leukotriene receptor 1 Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT281 Individual protein MAP kinase ERK1 Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT284 Individual protein Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT289 Individual protein Serotonin 1b (5-HT1b) receptor Rattus norvegicus IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT292 Individual protein Serotonin 2c (5-HT2c) receptor Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT2816 Individual protein Bromodomain-containing protein 4 Homo sapiens Delta TM = -0.66 C Tm Shift (DSF) assay results for EUbOPEN Chemogenomics Library
NPT1553 Individual protein Aminopeptidase N Sus scrofa IC50 = 2450.0 nM PMID[29202398]
NPT1553 Individual protein Aminopeptidase N Sus scrofa IC50 = 3700.0 nM PMID[27670098]
NPT2553 Individual protein Aminopeptidase N Homo sapiens IC50 = 20120.0 nM PMID[26629857]
NPT261 Individual protein Monoamine oxidase A Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT1553 Individual protein Aminopeptidase N Sus scrofa IC50 = 9400.0 nM PMID[29859750]
NPT224 Individual protein Alpha-2c adrenergic receptor Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT232 Individual protein Cannabinoid CB1 receptor Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT31 Individual protein Cyclooxygenase-2 Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT277 Individual protein Caspase-1 Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT286 Individual protein Receptor protein-tyrosine kinase erbB-2 Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT303 Individual protein Vasopressin V1a receptor Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT259 Individual protein Melanocortin receptor 4 Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT1553 Individual protein Aminopeptidase N Sus scrofa IC50 = 2700.0 nM PMID[17070058]
NPT267 Individual protein Neuropeptide Y receptor type 1 Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT272 Individual protein Kappa opioid receptor Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT288 Individual protein Serotonin 1a (5-HT1a) receptor Rattus norvegicus Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT1553 Individual protein Aminopeptidase N Sus scrofa IC50 = 9400.0 nM PMID[32791404]
NPT272 Individual protein Kappa opioid receptor Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT145 Individual protein Mu opioid receptor Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT280 Individual protein Matrix metalloproteinase 9 Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT14 Individual protein Tyrosine-protein kinase FYN Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT244 Individual protein Dopamine D3 receptor Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT1371 Individual protein Cyclin-dependent kinase 2 Homo sapiens Delta TM = 1.32 C Tm Shift (DSF) assay results for EUbOPEN Chemogenomics Library
NPT222 Individual protein Alpha-2a adrenergic receptor Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT2553 Individual protein Aminopeptidase N Homo sapiens IC50 = 2400.0 nM PMID[20129718]
NPT230 Individual protein Bradykinin B2 receptor Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT230 Individual protein Bradykinin B2 receptor Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT2553 Individual protein Aminopeptidase N Homo sapiens IC50 = 16270.0 nM PMID[29202398]
NPT232 Individual protein Cannabinoid CB1 receptor Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT1553 Individual protein Aminopeptidase N Sus scrofa IC50 = 14900.0 nM PMID[29630364]
NPT300 Individual protein Thromboxane-A synthase Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT290 Individual protein Serotonin 2a (5-HT2a) receptor Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT108 Individual protein Estrogen receptor alpha Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT292 Individual protein Serotonin 2c (5-HT2c) receptor Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT301 Individual protein Vascular endothelial growth factor receptor 1 Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT2719 Individual protein Voltage-gated L-type calcium channel alpha-1C subunit Rattus norvegicus AC50 > 30000.0 nM PMID[37468498]
NPT1553 Individual protein Aminopeptidase N Sus scrofa IC50 = 6900.0 nM PMID[26386821]
NPT2520 Individual protein Leukotriene A4 hydrolase Homo sapiens IC50 = 18010.0 nM PMID[28065501]
NPT109 Individual protein Cytochrome P450 3A4 Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT220 Individual protein Alpha-1b adrenergic receptor Rattus norvegicus IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT233 Individual protein Carbonic anhydrase II Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT236 Individual protein C-C chemokine receptor type 5 Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT297 Individual protein Neurokinin 1 receptor Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT2553 Individual protein Aminopeptidase N Homo sapiens IC50 = 35500.0 nM PMID[30737134]
NPT2553 Individual protein Aminopeptidase N Homo sapiens IC50 = 17290.0 nM PMID[27322756]
NPT256 Individual protein Cysteinyl leukotriene receptor 1 Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT276 Individual protein Angiotensin-converting enzyme Oryctolagus cuniculus Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT14 Individual protein Tyrosine-protein kinase FYN Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT3266 Individual protein Casein kinase I delta Homo sapiens Delta TM = 0.13 C Tm Shift (DSF) assay results for EUbOPEN Chemogenomics Library
NPT2520 Individual protein Leukotriene A4 hydrolase Homo sapiens IC50 = 4200.0 nM PMID[23220644]
NPT237 Individual protein Interleukin-8 receptor A Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT110 Individual protein Cytochrome P450 2D6 Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT241 Individual protein Cytochrome P450 2E1 Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT110 Individual protein Cytochrome P450 2D6 Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT291 Individual protein Serotonin 2b (5-HT2b) receptor Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT2553 Individual protein Aminopeptidase N Homo sapiens Inhibition n.a. n.a. % PMID[31126854]
NPT3227 Individual protein Fibroblast growth factor receptor 3 Homo sapiens Delta TM = 0.78 C Tm Shift (DSF) assay results for EUbOPEN Chemogenomics Library
NPT1553 Individual protein Aminopeptidase N Sus scrofa Inhibition <= 48.6 % PMID[36450011]
NPT2553 Individual protein Aminopeptidase N Homo sapiens IC50 > 100.0 ug.mL-1 PMID[10098663]
NPT1584 Individual protein Cytosol aminopeptidase Sus scrofa IC50 = 11200.0 nM PMID[27624521]
NPT1553 Individual protein Aminopeptidase N Sus scrofa IC50 = 13100.0 nM PMID[19339187]
NPT264 Individual protein Muscarinic acetylcholine receptor M3 Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT223 Individual protein Alpha-2b adrenergic receptor Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT31 Individual protein Cyclooxygenase-2 Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT2520 Individual protein Leukotriene A4 hydrolase Homo sapiens Delta Tm = 5.2 degrees C PMID[27651294]
NPT30 Individual protein Cyclooxygenase-1 Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT3172 Individual protein Phospholipase A2 group IIA Homo sapiens IC50 > 100000.0 nM PMID[23220644]
NPT1553 Individual protein Aminopeptidase N Sus scrofa IC50 = 3100.0 nM PMID[18996018]
NPT2553 Individual protein Aminopeptidase N Homo sapiens IC50 > 471600.0 nM PMID[10098663]
NPT1553 Individual protein Aminopeptidase N Sus scrofa IC50 = 9100.0 nM PMID[24900417]
NPT108 Individual protein Estrogen receptor alpha Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT299 Individual protein Androgen Receptor Rattus norvegicus AC50 > 30000.0 nM PMID[37468498]
NPT218 Individual protein Adenosine A3 receptor Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT249 Individual protein Glucocorticoid receptor Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT277 Individual protein Caspase-1 Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT282 Individual protein MAP kinase ERK2 Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT228 Individual protein Norepinephrine transporter Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT153 Individual protein Androgen Receptor Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT1241 Individual protein Oligopeptide transporter, kidney isoform Rattus norvegicus Activity n.a. n.a. n.a. PMID[8639691]
NPT224 Individual protein Alpha-2c adrenergic receptor Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT235 Individual protein C-C chemokine receptor type 4 Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT236 Individual protein C-C chemokine receptor type 5 Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT30 Individual protein Cyclooxygenase-1 Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT241 Individual protein Cytochrome P450 2E1 Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT262 Individual protein Muscarinic acetylcholine receptor M1 Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT1464 Individual protein Phosphodiesterase 4D Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT2520 Individual protein Leukotriene A4 hydrolase Homo sapiens Kd = 5150.0 nM PMID[27651294]
NPT2553 Individual protein Aminopeptidase N Homo sapiens IC50 = 3900.0 nM PMID[15582436]
NPT226 Individual protein Beta-2 adrenergic receptor Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT243 Individual protein Dopamine D2 receptor Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT13 Individual protein Tyrosine-protein kinase LCK Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT295 Individual protein Serotonin transporter Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT2520 Individual protein Leukotriene A4 hydrolase Homo sapiens IC50 = 500.0 nM PMID[21292493]
NPT272 Individual protein Kappa opioid receptor Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT2553 Individual protein Aminopeptidase N Homo sapiens IC50 = 3500.0 nM PMID[21292493]
NPT2553 Individual protein Aminopeptidase N Homo sapiens IC50 = 0.81 ug.mL-1 PMID[9464355]
NPT2879 Individual protein Equilibrative nucleoside transporter 1 Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT217 Individual protein Adenosine A2a receptor Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT2553 Individual protein Aminopeptidase N Homo sapiens IC50 = 35500.0 nM PMID[29859750]
NPT1553 Individual protein Aminopeptidase N Sus scrofa IC50 = 3700.0 nM PMID[21802307]
NPT2553 Individual protein Aminopeptidase N Homo sapiens IC50 = 22890.0 nM PMID[21802307]
NPT2553 Individual protein Aminopeptidase N Homo sapiens IC50 = 2700.0 nM PMID[12873488]
NPT1553 Individual protein Aminopeptidase N Sus scrofa IC50 = 8500.0 nM PMID[18571419]
NPT226 Individual protein Beta-2 adrenergic receptor Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT204 Individual protein Acetylcholinesterase Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT2761 Individual protein Phosphodiesterase 4A Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT2553 Individual protein Aminopeptidase N Homo sapiens IC50 = 29670.0 nM PMID[21911297]
NPT251 Individual protein Histamine H1 receptor Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT5897 Individual protein Cystinyl aminopeptidase Rattus norvegicus Ki = 4400.0 nM PMID[2566685]
NPT3968 Individual protein Leucine aminopeptidase Homo sapiens Ki = 0.6 nM PMID[12801228]
NPT479 Individual protein Aminopeptidase B Rattus norvegicus Ki = 60.0 nM PMID[3184126]
NPT5897 Individual protein Cystinyl aminopeptidase Rattus norvegicus Ki = 20.0 nM PMID[2566685]
NPT3968 Individual protein Leucine aminopeptidase Homo sapiens Ki = 20.0 nM PMID[3184126]
NPT479 Individual protein Aminopeptidase B Rattus norvegicus Ki = 14.0 nM PMID[2566685]
NPT28363 Single protein Interleukin-1 receptor antagonist protein Homo sapiens IC50 > 100000.0 nM PMID[35833347]
NPT5927 Individual protein Aminopeptidase B Homo sapiens IC50 = 160000.0 nM PMID[27096037]
NPT479 Individual protein Aminopeptidase B Rattus norvegicus IC50 = 0.05 ug.mL-1 PMID[850237]
NPT72 Individual protein Solute carrier organic anion transporter family member 1B3 Homo sapiens Inhibition = 31.8 % PMID[22541068]
NPT3968 Individual protein Leucine aminopeptidase Homo sapiens IC50 = 11200.0 nM PMID[15582436]
NPT50 Individual protein Tyrosyl-DNA phosphodiesterase 1 Homo sapiens Potency n.a. 22387.2 nM PubChem BioAssay data set
NPT803 Individual protein Flap endonuclease 1 Homo sapiens Potency n.a. 8436.8 nM PubChem BioAssay data set
NPT479 Individual protein Aminopeptidase B Rattus norvegicus IC50 = 6000.0 nM PMID[1347791]
NPT987 Individual protein Histamine H3 receptor Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT68 Individual protein Aldose reductase Rattus norvegicus IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT4852 Individual protein Puromycin-sensitive aminopeptidase Homo sapiens IC50 = 3500.0 nM PMID[28803047]
NPT5924 Individual protein Cytosol aminopeptidase Bos taurus IC50 = 0.5 nM PMID[21292493]
NPT20556 Single protein Replicase polyprotein 1ab Severe acute respiratory syndrome coronavirus 2 Inhibition = 17.76 % Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen
NPT69 Individual protein Matrix metalloproteinase-1 Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT98 Individual protein HERG Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT5924 Individual protein Cytosol aminopeptidase Bos taurus Ki = 500.0 nM PMID[22796349]
NPT692 Individual protein Histone deacetylase 6 Homo sapiens Inhibition = 0.45 % HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators
NPT542 Individual protein Progesterone receptor Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT69 Individual protein Matrix metalloproteinase-1 Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT29498 Single protein Interleukin-8 receptor B Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT29430 Single protein Neuronal acetylcholine receptor protein alpha-4 subunit Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT20556 Single protein Replicase polyprotein 1ab Severe acute respiratory syndrome coronavirus 2 Inhibition = 11.61 % Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen
NPT68 Individual protein Aldose reductase Rattus norvegicus Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT29498 Single protein Interleukin-8 receptor B Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT73 Individual protein Solute carrier organic anion transporter family member 1B1 Homo sapiens Inhibition = 10.9 % PMID[22541068]
NPT98 Individual protein HERG Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT3903 Individual protein Endoplasmic reticulum aminopeptidase 2 Homo sapiens IC50 > 100000.0 nM PMID[35833347]
NPT20556 Single protein Replicase polyprotein 1ab Severe acute respiratory syndrome coronavirus 2 Inhibition = 20.76 % Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen
NPT3903 Individual protein Endoplasmic reticulum aminopeptidase 2 Homo sapiens Inhibition = 100.0 % PMID[33359953]
NPT4015 Individual protein Matrix metalloproteinase 14 Homo sapiens IC50 n.a. n.a. nM PMID[15582436]
NPT692 Individual protein Histone deacetylase 6 Homo sapiens Inhibition = 2.33 % HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators
NPT98 Individual protein HERG Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT92 Individual protein Serotonin 1a (5-HT1a) receptor Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT591 Individual protein Glycogen synthase kinase-3 beta Homo sapiens Delta TM = 0.33 C Tm Shift (DSF) assay results for EUbOPEN Chemogenomics Library
NPT5921 Individual protein Zinc aminopeptidase Plasmodium falciparum FcB1/Columbia Ki = 190.0 nM PMID[21366301]
NPT5921 Individual protein Zinc aminopeptidase Plasmodium falciparum FcB1/Columbia IC50 = 284.0 nM PMID[12873488]
NPT20859 Single protein Neuropeptide Y receptor type 2 Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT622 Individual protein Solute carrier organic anion transporter family member 2B1 Homo sapiens Inhibition = 20.7 % PMID[22541068]
NPT478 Individual protein Ataxin-2 Homo sapiens Potency n.a. 398.1 nM PubChem BioAssay data set
NPT5104 Individual protein Phosphodiesterase 3A Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT5975 Individual protein Cyclooxygenase-1 Rattus norvegicus AC50 > 30000.0 nM PMID[37468498]
NPT20859 Single protein Neuropeptide Y receptor type 2 Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT30010 Single protein Calcitonin receptor Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT543 Individual protein Pregnane X receptor Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT568 Individual protein Matrix metalloproteinase-2 Homo sapiens IC50 = 162000.0 nM PMID[19454370]
NPT568 Individual protein Matrix metalloproteinase-2 Homo sapiens IC50 = 156000.0 nM PMID[23528299]
NPT5 Individual protein Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 Homo sapiens Potency n.a. 22387.2 nM PubChem BioAssay data set
NPT29442 Protein complex group Glycine receptor Rattus norvegicus Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT28550 Single protein Vasoactive intestinal polypeptide receptor 1 Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT30010 Single protein Calcitonin receptor Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT28398 Single protein Insulin receptor Rattus norvegicus IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT568 Individual protein Matrix metalloproteinase-2 Homo sapiens IC50 = 9500.0 nM PMID[18571419]
NPT5920 Individual protein Bacterial leucyl aminopeptidase Vibrio proteolyticus Ki = 1.6 nM PMID[24055078]
NPT568 Individual protein Matrix metalloproteinase-2 Homo sapiens IC50 n.a. n.a. nM PMID[15582436]
NPT568 Individual protein Matrix metalloproteinase-2 Homo sapiens IC50 = 253200.0 nM PMID[19969464]
NPT568 Individual protein Matrix metalloproteinase-2 Homo sapiens IC50 = 40500.0 nM PMID[19339187]
NPT568 Individual protein Matrix metalloproteinase-2 Homo sapiens IC50 = 162000.0 nM PMID[18996018]
NPT5922 Individual protein Aminopeptidase B Mus musculus IC50 = 6000.0 nM DOI[10.1016/S0960-894X(01)80519-9]
NPT3904 Individual protein Endoplasmic reticulum aminopeptidase 1 Homo sapiens IC50 = 50000.0 nM PMID[27437077]
NPT568 Individual protein Matrix metalloproteinase-2 Homo sapiens IC50 = 162000.0 nM PMID[19782572]
NPT62 Individual protein 6-phospho-1-fructokinase Trypanosoma brucei Potency n.a. 8492.1 nM PubChem BioAssay data set
NPT568 Individual protein Matrix metalloproteinase-2 Homo sapiens IC50 = 156000.0 nM PMID[22607877]
NPT568 Individual protein Matrix metalloproteinase-2 Homo sapiens IC50 = 163480.0 nM PMID[21911297]
NPT29442 Protein complex group Glycine receptor Rattus norvegicus IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT30151 Single protein Melanocortin receptor 3 Homo sapiens Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT568 Individual protein Matrix metalloproteinase-2 Homo sapiens IC50 > 100000.0 nM PMID[24755524]
NPT568 Individual protein Matrix metalloproteinase-2 Homo sapiens IC50 = 156980.0 nM PMID[20637634]
NPT4744 Individual protein M17 leucyl aminopeptidase Plasmodium falciparum 3D7 Inhibition = 93.0 % PMID[18458130]
NPT568 Individual protein Matrix metalloproteinase-2 Homo sapiens IC50 = 21960.0 nM PMID[18467109]
NPT568 Individual protein Matrix metalloproteinase-2 Homo sapiens IC50 n.a. n.a. n.a. PMID[26386821]
NPT5925 Individual protein Aminopeptidase N Mus musculus Ki = 3030.0 nM PMID[24900417]
NPT568 Individual protein Matrix metalloproteinase-2 Homo sapiens IC50 = 3400.0 nM PMID[17433673]
NPT568 Individual protein Matrix metalloproteinase-2 Homo sapiens IC50 = 40500.0 nM PMID[19329328]
NPT30151 Single protein Melanocortin receptor 3 Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT5923 Individual protein Aminopeptidase N Rattus norvegicus IC50 = 19400.0 nM PMID[1347791]
NPT568 Individual protein Matrix metalloproteinase-2 Homo sapiens Inhibition n.a. n.a. % PMID[26386821]
NPT28550 Single protein Vasoactive intestinal polypeptide receptor 1 Homo sapiens IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT3904 Individual protein Endoplasmic reticulum aminopeptidase 1 Homo sapiens IC50 = 45000.0 nM PMID[35833347]
NPT28927 Single protein Peregrin Homo sapiens Delta TM = -2.93 C Tm Shift (DSF) assay results for EUbOPEN Chemogenomics Library
NPT24040 Single protein Transcription intermediary factor 1-alpha Homo sapiens Delta TM = -0.82 C Tm Shift (DSF) assay results for EUbOPEN Chemogenomics Library
NPT4744 Individual protein M17 leucyl aminopeptidase Plasmodium falciparum 3D7 Inhibition = 33.0 % PMID[18458130]
NPT4744 Individual protein M17 leucyl aminopeptidase Plasmodium falciparum 3D7 Inhibition = 98.0 % PMID[18458130]
NPT5925 Individual protein Aminopeptidase N Mus musculus IC50 = 23200.0 nM PMID[24900417]
NPT4744 Individual protein M17 leucyl aminopeptidase Plasmodium falciparum 3D7 Inhibition = 6.0 % PMID[18458130]
NPT568 Individual protein Matrix metalloproteinase-2 Homo sapiens IC50 = 276000.0 nM PMID[24900417]
NPT4744 Individual protein M17 leucyl aminopeptidase Plasmodium falciparum 3D7 Inhibition = 47.0 % PMID[18458130]
NPT28398 Single protein Insulin receptor Rattus norvegicus Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT30151 Single protein Melanocortin receptor 3 Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT568 Individual protein Matrix metalloproteinase-2 Homo sapiens IC50 = 120400.0 nM PMID[21802307]
NPT670 Individual protein Thrombin Homo sapiens AC50 > 30000.0 nM PMID[37468498]
NPT425 Individual protein Serotonin 3a (5-HT3a) receptor Homo sapiens AC50 > 30000.0 nM PMID[37468498]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1357 Cell line H22 Mus musculus TGI = 45.37 % PMID[20129718]
NPT4611 Cell line PLC-PRF-5 Homo sapiens Activity n.a. n.a. n.a. PMID[29202398]
NPT116 Cell line HL-60 Homo sapiens IC50 = 1650000.0 nM PMID[19423354]
NPT81 Cell line A549 Homo sapiens IC50 > 500000.0 nM PMID[29202398]
NPT82 Cell line MDA-MB-231 Homo sapiens IC50 > 500000.0 nM PMID[29859750]
NPT82 Cell line MDA-MB-231 Homo sapiens Activity n.a. n.a. n.a. PMID[31126854]
NPT737 Cell line HUVEC Homo sapiens Inhibition n.a. n.a. % PMID[29859750]
NPT116 Cell line HL-60 Homo sapiens IC50 = 1650000.0 nM PMID[18996018]
NPT400 Cell line MDA-MB-435 Homo sapiens Inhibition n.a. n.a. % PMID[23664876]
NPT737 Cell line HUVEC Homo sapiens Activity n.a. n.a. n.a. PMID[24900417]
NPT83 Cell line MCF7 Homo sapiens IC50 > 500000.0 nM PMID[27322756]
NPT4611 Cell line PLC-PRF-5 Homo sapiens IC50 > 500000.0 nM PMID[27322756]
NPT116 Cell line HL-60 Homo sapiens IC50 = 245000.0 nM PMID[22206607]
NPT1357 Cell line H22 Mus musculus Activity = 60.25 % PMID[19683842]
NPT116 Cell line HL-60 Homo sapiens IC50 = 1130000.0 nM PMID[20637634]
NPT737 Cell line HUVEC Homo sapiens Inhibition n.a. n.a. % PMID[29202398]
NPT81 Cell line A549 Homo sapiens IC50 > 500000.0 nM PMID[27670098]
NPT393 Cell line HCT-116 Homo sapiens Ratio IC50 = 1.83 n.a. PMID[28065501]
NPT4611 Cell line PLC-PRF-5 Homo sapiens Activity = 0.0 % PMID[29202398]
NPT4611 Cell line PLC-PRF-5 Homo sapiens Activity = 3.59 % PMID[29202398]
NPT116 Cell line HL-60 Homo sapiens IC50 = 245000.0 nM PMID[19683842]
NPT196 Cell line AGS Homo sapiens IC50 > 200000.0 nM PMID[34917257]
NPT81 Cell line A549 Homo sapiens IC50 > 500000.0 nM PMID[30737134]
NPT165 Cell line HeLa Homo sapiens IC50 > 500000.0 nM PMID[27670098]
NPT519 Cell line SH-SY5Y Homo sapiens Potency n.a. 398.1 nM PubChem BioAssay data set
NPT4611 Cell line PLC-PRF-5 Homo sapiens Activity = 7.1 % PMID[27670098]
NPT82 Cell line MDA-MB-231 Homo sapiens IC50 = 8590000.0 nM PMID[20637634]
NPT111 Cell line K562 Homo sapiens IC50 > 500000.0 nM PMID[30737134]
NPT82 Cell line MDA-MB-231 Homo sapiens IC50 = 753180.0 nM PMID[21911297]
NPT111 Cell line K562 Homo sapiens IC50 > 500000.0 nM PMID[29859750]
NPT116 Cell line HL-60 Homo sapiens IC50 = 920000.0 nM PMID[19299146]
NPT306 Cell line PC-3 Homo sapiens IC50 > 500000.0 nM PMID[29859750]
NPT1357 Cell line H22 Mus musculus Inhibition = 75.9 % PMID[26629857]
NPT4611 Cell line PLC-PRF-5 Homo sapiens Activity = 13.0 % PMID[29202398]
NPT111 Cell line K562 Homo sapiens IC50 > 500000.0 nM PMID[32791404]
NPT4611 Cell line PLC-PRF-5 Homo sapiens IC50 = 22810.0 nM PMID[29202398]
NPT466 Cell line U-937 Homo sapiens IC50 > 500000.0 nM PMID[32791404]
NPT2711 Cell line BALB/3T3 Mus musculus GI = 37.7 % PMID[27624521]
NPT461 Cell line PANC-1 Homo sapiens Activity > 10.0 % PMID[20347318]
NPT4611 Cell line PLC-PRF-5 Homo sapiens IC50 > 500000.0 nM PMID[29202398]
NPT737 Cell line HUVEC Homo sapiens IC50 > 2000000.0 nM PMID[30737134]
NPT737 Cell line HUVEC Homo sapiens Inhibition n.a. n.a. % PMID[30737134]
NPT82 Cell line MDA-MB-231 Homo sapiens IC50 = 5080000.0 nM PMID[21802307]
NPT393 Cell line HCT-116 Homo sapiens IC50 = 357610.0 nM PMID[29202398]
NPT2615 Cell line HEK-293T Homo sapiens Growth Rate = 0.55 n.a. EUbOPEN Chemogenomics Library - IncuCyte
NPT393 Cell line HCT-116 Homo sapiens IC50 > 1000000.0 nM PMID[22901392]
NPT4611 Cell line PLC-PRF-5 Homo sapiens Activity = 33.3 % PMID[29202398]
NPT4611 Cell line PLC-PRF-5 Homo sapiens Activity = 64.3 % PMID[29202398]
NPT466 Cell line U-937 Homo sapiens IC50 > 500000.0 nM PMID[29859750]
NPT81 Cell line A549 Homo sapiens IC50 > 500000.0 nM PMID[29859750]
NPT1045 Cell line U2OS Homo sapiens Growth Rate = 0.42 n.a. EUbOPEN Chemogenomics Library - IncuCyte
NPT306 Cell line PC-3 Homo sapiens IC50 > 500000.0 nM PMID[32791404]
NPT2192 Cell line HEL Homo sapiens IC50 > 500000.0 nM PMID[27670098]
NPT466 Cell line U-937 Homo sapiens IC50 = 142630.0 nM PMID[27670098]
NPT82 Cell line MDA-MB-231 Homo sapiens IC50 > 500000.0 nM PMID[27670098]
NPT306 Cell line PC-3 Homo sapiens IC50 = 399400.0 nM PMID[22901392]
NPT111 Cell line K562 Homo sapiens IC50 = 135600.0 nM PMID[22901392]
NPT2015 Cell line U-266 Homo sapiens IC50 > 500000.0 nM PMID[29202398]
NPT4611 Cell line PLC-PRF-5 Homo sapiens IC50 > 500000.0 nM PMID[32791404]
NPT4611 Cell line PLC-PRF-5 Homo sapiens Activity = 0.01 % PMID[29202398]
NPT81 Cell line A549 Homo sapiens IC50 = 512900.0 nM PMID[22901392]
NPT116 Cell line HL-60 Homo sapiens IC50 = 86400.0 nM PMID[22901392]
NPT82 Cell line MDA-MB-231 Homo sapiens Activity = 2.14 % PMID[22901392]
NPT83 Cell line MCF7 Homo sapiens Activity n.a. n.a. n.a. PMID[27253989]
NPT83 Cell line MCF7 Homo sapiens Activity = 3.4 % PMID[27253989]
NPT83 Cell line MCF7 Homo sapiens GI = 63.8 % PMID[27624521]
NPT82 Cell line MDA-MB-231 Homo sapiens Activity = 7.03 % PMID[22901392]
NPT4611 Cell line PLC-PRF-5 Homo sapiens Activity = 2.38 % PMID[29202398]
NPT2015 Cell line U-266 Homo sapiens IC50 = 43480.0 nM PMID[29202398]
NPT1045 Cell line U2OS Homo sapiens Growth Rate = 0.94 n.a. EUbOPEN Chemogenomics Library - IncuCyte
NPT737 Cell line HUVEC Homo sapiens Activity n.a. n.a. n.a. PMID[23528299]
NPT2615 Cell line HEK-293T Homo sapiens Growth Rate = 0.49 n.a. EUbOPEN Chemogenomics Library - IncuCyte
NPT306 Cell line PC-3 Homo sapiens IC50 > 500000.0 nM PMID[27670098]
NPT2015 Cell line U-266 Homo sapiens IC50 > 500000.0 nM PMID[27670098]
NPT83 Cell line MCF7 Homo sapiens IC50 > 1000000.0 nM PMID[22901392]
NPT165 Cell line HeLa Homo sapiens IC50 = 154900.0 nM PMID[22901392]
NPT453 Cell line HT-1080 Homo sapiens Activity > 10.0 % PMID[20347318]
NPT111 Cell line K562 Homo sapiens IC50 > 500000.0 nM PMID[27670098]
NPT393 Cell line HCT-116 Homo sapiens IC50 = 315250.0 nM PMID[27322756]
NPT466 Cell line U-937 Homo sapiens IC50 > 1000000.0 nM PMID[23453219]
NPT737 Cell line HUVEC Homo sapiens Activity n.a. n.a. n.a. PMID[34917257]
NPT4611 Cell line PLC-PRF-5 Homo sapiens IC50 > 500000.0 nM PMID[27670098]
NPT83 Cell line MCF7 Homo sapiens Activity = 7.5 % PMID[27253989]
NPT82 Cell line MDA-MB-231 Homo sapiens IC50 = 50600.0 nM PMID[22901392]
NPT165 Cell line HeLa Homo sapiens Inhibition = 28.0 % PMID[28803047]
NPT65 Cell line HepG2 Homo sapiens IC50 > 500000.0 nM PMID[32791404]
NPT1357 Cell line H22 Mus musculus Activity n.a. n.a. n.a. PMID[30737134]
NPT83 Cell line MCF7 Homo sapiens IC50 = 541000.0 nM PMID[27253989]
NPT2678 Cell line NB-4 Homo sapiens IC50 = 220900.0 nM PMID[22901392]
NPT82 Cell line MDA-MB-231 Homo sapiens Activity = 15.06 % PMID[22901392]
NPT1045 Cell line U2OS Homo sapiens Growth Rate = 0.89 n.a. EUbOPEN Chemogenomics Library - IncuCyte
NPT306 Cell line PC-3 Homo sapiens IC50 > 500000.0 nM PMID[30737134]
NPT65 Cell line HepG2 Homo sapiens IC50 > 500000.0 nM PMID[27322756]
NPT4611 Cell line PLC-PRF-5 Homo sapiens Activity = 11.0 % PMID[27670098]
NPT81 Cell line A549 Homo sapiens IC50 > 500000.0 nM PMID[27322756]
NPT737 Cell line HUVEC Homo sapiens Activity n.a. n.a. n.a. PMID[27322756]
NPT2341 Cell line NCI-H1975 Homo sapiens IC50 > 200000.0 nM PMID[34917257]
NPT116 Cell line HL-60 Homo sapiens EC50 > 100000.0 nM PMID[28803047]
NPT1357 Cell line H22 Mus musculus Activity = 64.0 % PMID[29859750]
NPT2615 Cell line HEK-293T Homo sapiens Growth Rate = 0.14 n.a. EUbOPEN Chemogenomics Library - IncuCyte
NPT2192 Cell line HEL Homo sapiens IC50 = 416650.0 nM PMID[27322756]
NPT4611 Cell line PLC-PRF-5 Homo sapiens Activity = 83.4 % PMID[29202398]
NPT82 Cell line MDA-MB-231 Homo sapiens Activity n.a. n.a. n.a. PMID[22901392]
NPT306 Cell line PC-3 Homo sapiens IC50 > 500000.0 nM PMID[27322756]
NPT83 Cell line MCF7 Homo sapiens IC50 > 200000.0 nM PMID[34917257]
NPT171 Cell line MRC5 Homo sapiens IC50 n.a. n.a. n.a. PMID[23176597]
NPT737 Cell line HUVEC Homo sapiens Inhibition n.a. n.a. % PMID[23428964]
NPT112 Cell line MOLT-4 Homo sapiens EC50 > 100000.0 nM PMID[28803047]
NPT1045 Cell line U2OS Homo sapiens Growth Rate = 0.82 n.a. EUbOPEN Chemogenomics Library - IncuCyte
NPT146 Cell line SK-OV-3 Homo sapiens IC50 > 1000000.0 nM PMID[22901392]
NPT82 Cell line MDA-MB-231 Homo sapiens Activity = 8.54 % PMID[22901392]
NPT81 Cell line A549 Homo sapiens IC50 = 15930.0 nM PMID[29202398]
NPT393 Cell line HCT-116 Homo sapiens IC50 = 44060.0 nM PMID[29202398]
NPT65 Cell line HepG2 Homo sapiens IC50 > 500000.0 nM PMID[29202398]
NPT886 Cell line NIH3T3 Mus musculus IC50 > 1000000.0 nM PMID[22901392]
NPT83 Cell line MCF7 Homo sapiens IC50 = 149600.0 nM PMID[27624521]
NPT466 Cell line U-937 Homo sapiens IC50 = 9560.0 nM PMID[29202398]
NPT466 Cell line U-937 Homo sapiens IC50 = 142630.0 nM PMID[29202398]
NPT165 Cell line HeLa Homo sapiens IC50 > 500000.0 nM PMID[27322756]
NPT114 Cell line LoVo Homo sapiens GI = 54.8 % PMID[27624521]
NPT82 Cell line MDA-MB-231 Homo sapiens Activity = 77.91 % PMID[22901392]
NPT2615 Cell line HEK-293T Homo sapiens Growth Rate = 0.59 n.a. EUbOPEN Chemogenomics Library - IncuCyte
NPT82 Cell line MDA-MB-231 Homo sapiens IC50 > 500000.0 nM PMID[27322756]
NPT65 Cell line HepG2 Homo sapiens IC50 = 14520.0 nM PMID[29202398]
NPT5420 Cell line MCF10 Homo sapiens GI = 26.9 % PMID[27624521]
NPT81 Cell line A549 Homo sapiens GI = 48.0 % PMID[27624521]
NPT2615 Cell line HEK-293T Homo sapiens Growth Rate = 0.98 n.a. EUbOPEN Chemogenomics Library - IncuCyte
NPT2615 Cell line HEK-293T Homo sapiens Growth Rate = 0.92 n.a. EUbOPEN Chemogenomics Library - IncuCyte
NPT116 Cell line HL-60 Homo sapiens IC50 n.a. n.a. n.a. PMID[27624521]
NPT82 Cell line MDA-MB-231 Homo sapiens IC50 = 50600.0 nM PMID[23510562]
NPT116 Cell line HL-60 Homo sapiens IC50 = 1340000.0 nM PMID[21802307]
NPT1357 Cell line H22 Mus musculus Inhibition = 45.37 % PMID[22206607]
NPT393 Cell line HCT-116 Homo sapiens IC50 > 500000.0 nM PMID[29859750]
NPT116 Cell line HL-60 Homo sapiens IC50 = 920000.0 nM PMID[19782572]
NPT466 Cell line U-937 Homo sapiens Cytotoxicity > 40.0 % PMID[12930151]
NPT28438 Unchecked Unchecked n.a. Activity n.a. n.a. n.a. PMID[17895246]
NPT28438 Unchecked Unchecked n.a. IC50 n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT28438 Unchecked Unchecked n.a. Ki n.a. n.a. n.a. DrugMatrix in vitro pharmacology data
NPT20555 Organism SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 IC50 > 20000.0 nM Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity
NPT28438 Unchecked Unchecked n.a. Ki < 160.0 nM PMID[28728898]
NPT20555 Organism SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Inhibition = -0.12 % Cytopathic SARS-Cov2 screening on VERO-E6 cells in a large repurposing effort
NPT28438 Unchecked Unchecked n.a. IC50 > 500000.0 nM PMID[27670098]
NPT28438 Unchecked Unchecked n.a. IC50 = 7000.0 nM PMID[21396812]
NPT28438 Unchecked Unchecked n.a. Activity = 1.2 % PMID[28728898]
NPT28438 Unchecked Unchecked n.a. IC50 > 500000.0 nM PMID[27322756]
NPT28438 Unchecked Unchecked n.a. IC50 < 310.0 nM PMID[28728898]
NPT28438 Unchecked Unchecked n.a. Inhibition = 50.0 % PMID[28728898]
NPT28438 Unchecked Unchecked n.a. IC50 > 500000.0 nM PMID[30737134]
NPT28438 Unchecked Unchecked n.a. Activity n.a. n.a. n.a. PMID[30737134]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 21000.0 nM PMID[28728898]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum Inhibition = 29.0 % PMID[18458130]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum EC50 = 5100.0 nM PMID[17088482]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 3200.0 nM PMID[21366301]
NPT20555 Organism SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Inhibition = 0.11 % Cytopathic SARS-Cov2 screening on VERO-E6 cells in a large repurposing effort
NPT28438 Unchecked Unchecked n.a. IC50 = 0.01 ug.mL-1 PMID[850237]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 29000.0 nM PMID[12873488]
NPT28438 Unchecked Unchecked n.a. IC50 = 17580.0 nM PMID[29202398]
NPT28438 Unchecked Unchecked n.a. Potency n.a. 31622.8 nM PubChem BioAssay data set
NPT28438 Unchecked Unchecked n.a. IC50 > 200000.0 nM PMID[20180535]
NPT28438 Unchecked Unchecked n.a. Ki = 478.0 nM PMID[33534577]
NPT20555 Organism SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 IC50 > 19952.62 nM Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 5000.0 nM PMID[33534577]
NPT28438 Unchecked Unchecked n.a. IC50 = 478.0 nM PMID[23176597]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 8.0 nM PMID[23176597]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum EC50 = 1800.0 nM PMID[17895246]
NPT24972 Cell line 3LL cell line Mus musculus Inhibition = 50.0 % PMID[24900417]
NPT28438 Unchecked Unchecked n.a. IC50 > 500000.0 nM PMID[29859750]
NPT28438 Unchecked Unchecked n.a. IC50 > 500000.0 nM PMID[29202398]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum Activity n.a. n.a. n.a. PMID[17895246]
NPT28438 Unchecked Unchecked n.a. Hepatotoxicity (malignant tumour) = 0.0 n.a. PMID[15646539]
NPT28438 Unchecked Unchecked n.a. IC50 = 300.0 nM PMID[1347791]
NPT28438 Unchecked Unchecked n.a. Hepatotoxicity (acute) = 0.0 n.a. PMID[15646539]
NPT28438 Unchecked Unchecked n.a. IC50 = 37050.0 nM PMID[29202398]
NPT20555 Organism SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Hit score = 0.1422 n.a. Identification of potential treatments for COVID-19 through artificial intelligence-enabled phenomic analysis of human cells infected with SARS-CoV-2
NPT28438 Unchecked Unchecked n.a. Ki = 1530.0 nM PMID[31251594]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum EC50 = 900.0 nM PMID[17895246]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 3300.0 nM PMID[28728898]
NPT28438 Unchecked Unchecked n.a. Ratio Ki > 13.1 n.a. PMID[28728898]
NPT28438 Unchecked Unchecked n.a. Inhibition n.a. n.a. % PMID[24900417]
NPT28438 Unchecked Unchecked n.a. IC50 = 170.0 nM PMID[3184127]
NPT28438 Unchecked Unchecked n.a. Ki = 25.0 nM PMID[33534577]
NPT30075 Cell line KG-1 Homo sapiens IC50 > 500000.0 nM PMID[27670098]
NPT20555 Organism SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Inhibition index = 0.01222 n.a. In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication
NPT28833 No target No relevant target n.a. Rf = 0.48 n.a. PMID[850237]
NPT28438 Unchecked Unchecked n.a. Hepatotoxicity (comment) n.a. n.a. n.a. PMID[15646539]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum Activity = 36.0 % PMID[28728898]
NPT28438 Unchecked Unchecked n.a. Ki = 1673.0 nM PMID[33534577]
NPT28833 No target No relevant target n.a. solubility n.a. n.a. n.a. PMID[19618939]
NPT28438 Unchecked Unchecked n.a. Ki = 1.6 nM PMID[33534577]
NPT28438 Unchecked Unchecked n.a. Ratio IC50 = 0.71 n.a. PMID[17433673]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum EC50 n.a. n.a. n.a. PMID[17088482]
NPT27870 Cell line HL60/MX2 Homo sapiens IC50 n.a. n.a. n.a. PMID[27624521]
NPT28438 Unchecked Unchecked n.a. IC50 n.a. n.a. n.a. PMID[27624521]
NPT28438 Unchecked Unchecked n.a. Ratio = 0.1 n.a. PMID[12873488]
NPT28438 Unchecked Unchecked n.a. Ratio IC50 = 30.2 n.a. PMID[24900417]
NPT20555 Organism SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Inhibition = 0.08 % Cytopathic SARS-Cov2 screening on VERO-E6 cells in a large repurposing effort
NPT28438 Unchecked Unchecked n.a. GI = 26.9 % PMID[27624521]
NPT28438 Unchecked Unchecked n.a. IC50 = 15500.0 nM PMID[18467109]
NPT28438 Unchecked Unchecked n.a. IC50 = 7000.0 nM PMID[30544037]
NPT30075 Cell line KG-1 Homo sapiens IC50 > 500000.0 nM PMID[27322756]
NPT28438 Unchecked Unchecked n.a. Inhibition n.a. n.a. % PMID[30537832]
NPT20555 Organism SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Inhibition = 1.62 % Identification of inhibitors of SARS-CoV-2 in-vitro cellular toxicity in human (Caco-2) cells using a large scale drug repurposing collection
NPT28438 Unchecked Unchecked n.a. Ki = 478.2 nM PMID[33534577]
NPT28438 Unchecked Unchecked n.a. Ki = 623000.0 nM PMID[33534577]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 14870.0 nM PMID[33534577]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum Inhibition = 97.0 % PMID[18458130]
NPT28438 Unchecked Unchecked n.a. IC50 = 4410.0 nM PMID[21396812]
NPT28438 Unchecked Unchecked n.a. Ratio IC50 = 42.6 n.a. PMID[19454370]
NPT28438 Unchecked Unchecked n.a. Ratio IC50 = 32.5 n.a. PMID[21802307]
NPT28438 Unchecked Unchecked n.a. IC50 = 1.6 nM PMID[21292493]
NPT28438 Unchecked Unchecked n.a. IC50 = 25000.0 nM PMID[21396812]
NPT28438 Unchecked Unchecked n.a. Hepatotoxicity (successful reintroduction) n.a. n.a. n.a. PMID[15646539]
NPT28438 Unchecked Unchecked n.a. Hepatotoxicity (association with vascular disease) = 0.0 n.a. PMID[15646539]
NPT28438 Unchecked Unchecked n.a. Hepatotoxicity (cytolytic) = 0.0 n.a. PMID[15646539]
NPT28438 Unchecked Unchecked n.a. Hepatotoxicity (cirrhosis) = 0.0 n.a. PMID[15646539]
NPT28438 Unchecked Unchecked n.a. Hepatotoxicity (steatosis) = 0.0 n.a. PMID[15646539]
NPT28438 Unchecked Unchecked n.a. Hepatotoxicity (choleostasis) = 0.0 n.a. PMID[15646539]
NPT28438 Unchecked Unchecked n.a. Hepatotoxicity (chronic liver disease) = 0.0 n.a. PMID[15646539]
NPT28438 Unchecked Unchecked n.a. Hepatotoxicity (severe hepatitis) = 0.0 n.a. PMID[15646539]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. IC50 = 332000.0 nM PMID[21194957]
NPT28895 Protein family Histone deacetylase 1/3/5/8 Homo sapiens IC50 > 1000000.0 nM PMID[23860593]
NPT23300 Cell line PLC Homo sapiens IC50 > 500000.0 nM PMID[30737134]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 36.2 % PMID[20129718]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. IC50 = 490000.0 nM PMID[22607877]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Inhibition n.a. n.a. % PMID[22607877]
NPT177 Tissue Aorta Rattus norvegicus Activity n.a. n.a. n.a. PMID[23528299]
NPT23300 Cell line PLC Homo sapiens IC50 > 500000.0 nM PMID[29859750]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Hepatotoxicity (mechanism) n.a. n.a. n.a. PMID[15646539]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. IC50 = 89510.0 nM PMID[28065501]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. IC50 = 620000.0 nM PMID[23453219]
NPT28895 Protein family Histone deacetylase 1/3/5/8 Homo sapiens IC50 > 100000.0 nM PMID[23453219]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. IC50 = 42540.0 nM PMID[28065501]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. IC50 = 631740.0 nM PMID[23510562]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. IC50 = 141890.0 nM PMID[21911297]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Activity n.a. n.a. n.a. PMID[23528299]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. GI50 = 350000.0 nM PMID[23528299]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Activity n.a. n.a. n.a. PMID[24900417]
NPT27866 Cell line B16-BL6 Mus musculus Inhibition = 50.0 % PMID[24900417]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Hepatotoxicity (acute) = 0.0 % PMID[15646539]
NPT177 Tissue Aorta Rattus norvegicus Activity n.a. n.a. n.a. PMID[27322756]
NPT173 Organism Klebsiella pneumoniae Klebsiella pneumoniae Inhibition = 12.45 % CO-ADD screening of NIH (USA) - Clinical Collection
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. IC50 = 74500.0 nM PMID[22901392]
NPT30138 Protein family Histone deacetylase Homo sapiens IC50 n.a. n.a. n.a. PMID[24755524]
NPT28797 Organism Cryptococcus neoformans Cryptococcus neoformans Inhibition = -0.18 % CO-ADD screening of NIH (USA) - Clinical Collection
NPT20 Organism Candida albicans Candida albicans Inhibition = 0.73 % CO-ADD screening of NIH (USA) - Clinical Collection
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. IC50 > 100.0 ug.mL-1 PMID[10098663]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. IC50 = 77820.0 nM PMID[28065501]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Inhibition n.a. n.a. % PMID[26629857]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Hepatotoxicity (animal toxicity known) n.a. n.a. n.a. PMID[15646539]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Hepatotoxicity (benign tumour) = 0.0 n.a. PMID[15646539]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Hepatotoxicity (moderate) = 2.4 % PMID[15646539]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Hepatotoxicity (granulomatous hepatitis) = 0.0 n.a. PMID[15646539]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Hepatotoxicity (moderate) = 1.0 n.a. PMID[15646539]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Hepatotoxicity (time to onset) n.a. n.a. n.a. PMID[15646539]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus Inhibition = 8.9 % CO-ADD screening of NIH (USA) - Clinical Collection
NPT29444 Cell line Fibroblast Homo sapiens Growth Rate = 0.83 n.a. EUbOPEN Chemogenomics Library - IncuCyte
NPT27732 Protein-protein interaction Plasminogen/Urokinase plasminogen activator surface receptor/Urokinase-type plasminogen activator Mus musculus Potency n.a. 16481.6 nM PubChem BioAssay data set
NPT20950 Cell line Erythrocyte n.a. Activity n.a. n.a. n.a. PMID[28728898]
NPT29444 Cell line Fibroblast Homo sapiens Growth Rate = 0.91 n.a. EUbOPEN Chemogenomics Library - IncuCyte
NPT2847 Tissue Thoracic aorta Rattus norvegicus Activity n.a. n.a. n.a. PMID[29859750]
NPT29444 Cell line Fibroblast Homo sapiens Growth Rate = -0.85 n.a. EUbOPEN Chemogenomics Library - IncuCyte
NPT19 Organism Escherichia coli Escherichia coli GI n.a. n.a. n.a. PMID[30544037]
NPT29444 Cell line Fibroblast Homo sapiens Growth Rate = 0.72 n.a. EUbOPEN Chemogenomics Library - IncuCyte
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa Inhibition = 8.82 % CO-ADD screening of NIH (USA) - Clinical Collection
NPT19 Organism Escherichia coli Escherichia coli Inhibition = -1.57 % CO-ADD screening of NIH (USA) - Clinical Collection
NPT2847 Tissue Thoracic aorta Rattus norvegicus Activity n.a. n.a. n.a. PMID[30737134]
NPT30043 Cell line Vero Chlorocebus sabaeus CC50 >= 25000.0 nM PMID[28803047]
NPT747 Organism Acinetobacter baumannii Acinetobacter baumannii Inhibition = 16.7 % CO-ADD screening of NIH (USA) - Clinical Collection
NPT28345 Cell line ES-2 Homo sapiens IC50 > 500000.0 nM PMID[32791404]
NPT28638 Cell line Neutrophil Homo sapiens Inhibition n.a. n.a. % PMID[31751136]
NPT28544 Protein family Histone deacetylase (HDAC1 and HDAC2) Homo sapiens IC50 > 100000.0 nM PMID[26629857]
NPT28544 Protein family Histone deacetylase (HDAC1 and HDAC2) Homo sapiens Inhibition n.a. n.a. % PMID[26386821]
NPT2849 Organism Plasmodium chabaudi Plasmodium chabaudi Activity = 34.0 % PMID[33534577]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT32 Organism Mus musculus Mus musculus Change = 59.0 % PMID[1347791]
NPT32 Organism Mus musculus Mus musculus Change = 3.0 % PMID[1347791]
NPT32 Organism Mus musculus Mus musculus Change = -3.0 % PMID[1347791]
NPT32 Organism Mus musculus Mus musculus Change = 11.0 % PMID[1347791]
NPT32 Organism Mus musculus Mus musculus Activity n.a. n.a. n.a. PMID[28218840]
NPT32 Organism Mus musculus Mus musculus Change = 41.0 % PMID[1347791]
NPT32 Organism Mus musculus Mus musculus Inhibition n.a. n.a. % PMID[28218840]
NPT32 Organism Mus musculus Mus musculus Change = 26.0 % PMID[1347791]
NPT29 Organism Rattus norvegicus Rattus norvegicus EOSLE = 0.0 % DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus MCHC = 387700.0 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus MONOLE = 1.0 % DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus RBC = 5820000.0 cells.uL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus HCT = 36.17 % DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus ALB = 42300.0 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus PROT = 61000.0 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus LYMLE = 94.33 % DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus BUN = 140.0 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus PROT = 57000.0 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus PROT = 60300.0 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus ALP = 310.67 U.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus EOS = 99.33 cells.uL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus RBCNUC = 0.0 /100WBC DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus LIPASE = 9.0 U.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus PROT = 58000.0 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus NEUTLE = 10.33 % DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus GLUC = 1556.7 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus NEUTSG = 847.0 cells.uL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus POTASSIUM = 5.18 mEq.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus CO2 = 31330000.0 nM DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus URATE = 17.0 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus POTASSIUM = 6.1 mEq.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus POTASSIUM = 5.71 mEq.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus AST = 87.0 U.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus PLAT = 1144330.0 cells.uL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus AST = 76.67 U.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus BILI = 1.7 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus SODIUM = 146.95 mEq.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus RBC = 5780000.0 cells.uL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus ALP = 304.33 U.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus PHOS = 105.3 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus SODIUM = 142.5 mEq.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus LYMLE = 89.67 % DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus SODIUM = 143.9 mEq.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus Tissue Severity Score n.a. n.a. n.a. DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus BASO = 0.0 cells.uL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus EOS = 0.0 cells.uL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus WBC = 16100.0 cells.uL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus WBC = 14170.0 cells.uL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus ALT = 48.33 U.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus LDH = 157.5 U.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus CHOL = 785.0 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus CO2 = 29330000.0 nM DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus PROT = 58500.0 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus NEUTLE = 8.17 % DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus SODIUM = 143.5 mEq.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus LDH = 498.67 U.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus PHOS = 112.0 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus MCH = 23.33 pg DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus PLAT = 1252670.0 cells.uL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus MCH = 24.53 pg DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus LIPASE = 10.17 U.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus VRT = 13.09 hr2 PMID[29202398]
NPT29 Organism Rattus norvegicus Rattus norvegicus MONO = 177.67 cells.uL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus LYMLE = 85.83 % DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus MCHC = 390000.0 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus NEUTLE = 13.33 % DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus MCV = 61.53 fL DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus PHOS = 110.7 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus HGB = 143300.0 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus ALT = 58.0 U.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus POTASSIUM = 6.61 mEq.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus NEUTSG = 1655.33 cells.uL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus EOSLE = 0.67 % DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus BUN = 163.3 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus CHLORIDE = 105.0 mEq.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus SODIUM = 144.27 mEq.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus BILI = 1.3 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus MONO = 122.0 cells.uL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus CO2 = 23670000.0 nM DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus LDH = 237.33 U.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus LYM = 12244.33 cells.uL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus MCHC = 403700.0 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus MCH = 24.6 pg DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus MCHC = 401700.0 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus MCV = 61.37 fL DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus HGB = 141000.0 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus EOS = 168.33 cells.uL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus LYM = 13654.17 cells.uL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus HGB = 139700.0 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus LYMLE = 89.83 % DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus MCV = 62.05 fL DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus MONOLE = 0.83 % DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus ALT = 50.83 U.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus BUN = 165.0 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus CHLORIDE = 103.5 mEq.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus CREAT = 2.1 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus HCT = 36.13 % DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus CHOL = 760.0 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus HGB = 140700.0 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus ALP = 334.17 U.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus HCT = 35.73 % DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus PROT = 62200.0 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus URATE = 18.3 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus HCT = 34.83 % DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus PHOS = 92.7 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus URATE = 14.7 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus ALB = 43000.0 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus ALP = 289.33 U.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus RBC = 5560000.0 cells.uL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus CREAT = 1.8 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus RBC = 5720000.0 cells.uL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus CK = 463.33 U.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus NEUTLE = 5.0 % DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus MCH = 24.63 pg DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus NEUTSG = 1690.33 cells.uL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus CREAT = 1.7 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus CK = 381.5 U.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus MCH = 24.42 pg DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus GLUC = 1618.3 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus WBC = 15830.0 cells.uL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus LIPASE = 9.33 U.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus NEUTSG = 1223.17 cells.uL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus RBC = 5700000.0 cells.uL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus WBC = 15170.0 cells.uL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus MONOLE = 2.0 % DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus CO2 = 26500000.0 nM DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus BILI = 2.2 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus MCV = 62.55 fL DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus MONO = 91.0 cells.uL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus NEUTLE = 8.0 % DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus PHOS = 118.3 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus MONO = 121.0 cells.uL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus BASOLE = 0.0 % DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus ALT = 55.5 U.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus AST = 92.5 U.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus CK = 272.17 U.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus AST = 82.17 U.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus GLUC = 1430.0 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus LYMLE = 88.33 % DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus LYM = 13954.33 cells.uL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus LDH = 228.67 U.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus BILI = 2.0 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus CO2 = 25670000.0 nM DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus CK = 350.33 U.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus CHOL = 800.0 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus CHLORIDE = 102.33 mEq.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus AST = 93.33 U.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus ALB = 41800.0 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus ALT = 53.33 U.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus CHLORIDE = 100.0 mEq.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus CK = 475.33 U.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus LDH = 612.67 U.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus CREAT = 2.3 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus URATE = 12.7 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus ALP = 308.67 U.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus GLUC = 1463.3 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus SODIUM = 150.27 mEq.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus BUN = 156.7 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus HCT = 35.33 % DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus ALB = 42200.0 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus MCHC = 395300.0 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus EOSLE = 0.33 % DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus PLAT = 1281170.0 cells.uL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus RBCNUC = 0.17 /100WBC DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus HGB = 140300.0 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus EOS = 88.0 cells.uL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus CHOL = 583.3 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus MONO = 144.0 cells.uL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus ALB = 40000.0 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus MONO = 277.67 cells.uL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus HCT = 33.13 % DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus URATE = 15.3 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus MCHC = 391700.0 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus URATE = 13.7 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus LYM = 15131.0 cells.uL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus ALT = 54.33 U.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus POTASSIUM = 6.4 mEq.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus ALP = 345.0 U.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus POTASSIUM = 6.78 mEq.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus CHLORIDE = 99.83 mEq.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus WBC = 15800.0 cells.uL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus EOSLE = 1.17 % DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus BUN = 155.0 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus PLAT = 1312170.0 cells.uL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus LYM = 13539.33 cells.uL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus NEUTSG = 2116.33 cells.uL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus LDH = 487.5 U.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus PHOS = 121.8 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus MCV = 59.53 fL DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus MONOLE = 0.67 % DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus RBC = 5870000.0 cells.uL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus MCH = 23.9 pg DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus CHOL = 633.3 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus MCV = 60.93 fL DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus CK = 244.67 U.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus LIPASE = 10.0 U.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus EOS = 28.67 cells.uL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus CREAT = 2.6 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus AST = 96.67 U.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus GLUC = 1420.0 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus HGB = 129700.0 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus BUN = 166.7 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus ALB = 41300.0 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus CREAT = 2.0 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus LIPASE = 9.67 U.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus CHOL = 623.3 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus PLAT = 1187670.0 cells.uL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus GLUC = 1976.7 ug.mL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus LYMLE = 86.33 % DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus CHLORIDE = 108.67 mEq.L-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus LYM = 12669.0 cells.uL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus NEUTSG = 1191.33 cells.uL-1 DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus NEUTLE = 12.0 % DrugMatrix
NPT29 Organism Rattus norvegicus Rattus norvegicus PLAT = 1238330.0 cells.uL-1 DrugMatrix





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference
Rattus norvegicus Plasma Drug metabolism n.a. n.a. n.a. PMID[29202398]





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
☉ ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
☉ TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC599805 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.78 Intermediate Similarity NPC607224
0.6923 Remote Similarity NPC327481
0.623 Remote Similarity NPC604301

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC599805 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.5862 Remote Similarity NPD2217 Approved
0.5862 Remote Similarity NPD2218 Phase 2
0.5094 Remote Similarity NPD9591 Approved

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
☉ A: chemistry similarity;
☉ B: biological targets similarity;
☉ C: networks similarity;
☉ D: cell-based bioactivity similarity;
☉ E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data